Acceliant Appoints Santhosh S. Nagaraj as Sales Head

14 Nov, 2012

Acceliant Logo
Santa Clara, California, November 14, 2012 - Acceliant, the medical industry technology division of Trianz, announces a new sales leadership with the appointment of Santhosh S. Nagaraj, who will be heading the sales for Acceliant suite of products in India.

Commenting on Santhosh's appointment, Sri Manchala, Chairman and CEO, said, "We are pleased to have Santhosh on board. Santhosh with his vast experience and commitment to sales execution is well-positioned to add momentum to Acceliant's sales strategies aiming at long-term benefits. Santhosh will focus on India, helping build awareness regarding clinical trial management and showcasing the advantages of clinical EDC. His expertise combined with that of our existing team will help foster continuous growth and success of Acceliant."

Santhosh comes with 16 years of experience in Sales, Business Development and Account Management. He has had global experience in diversified industries especially engineering and IT services. Santhosh has had significant experience in acquiring prestigious clients in the past. Prior to joining Acceliant, Santhosh has held sales leadership position with HCL America, Inc. and Cognizant Technology Solutions where he has managed and grown large manufacturing accounts and multi-million dollar portfolios.

Speaking on his appointment, Santhosh said, "I am glad to be a part of Acceliant, which is going through a phase of continuous improvements. I look forward to steer this growth in line with the spirit of the company's vision to lead the industry through technological innovation."

Santhosh holds a bachelor's degree in Mechanical Engineering from Bangalore University. He also has a diploma in Export Import Management from India International Trade Center.

Acceliant eClinical Suite

Acceliant eClinical Suite is competitive in meeting the challenges of today’s dynamic market conditions. The Acceliant eClinical Suite is a pre-eminent offering that continues its 12-year history of providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to implement and deploy in response to the data, functional, and analytic needs of clinical trials.

Prashant Bhavaraju